TabletAnti Diabetic

Sitagliptin + Pioglitazone

Sitagliptin + Pioglitazone · DPP-4 inhibitor and thiazolidinedione combination

TabletAnti Diabetic

Sitagliptin + PioglitazoneProspero Healthcare

A tablet combining sitagliptin, a DPP-4 inhibitor, with pioglitazone, an insulin-sensitising thiazolidinedione. It is used to improve glycaemic control in adults with type 2 diabetes mellitus.

Uses

Type 2 diabetes mellitus

Enquire about this product

Specifications are indicative; availability, composition, pack sizes and registration requirements may vary by destination market.

01Specification

Product details

Composition: Sitagliptin + Pioglitazone
Dosage form: Tablet
Therapeutic category: Anti Diabetic
Therapeutic class: DPP-4 inhibitor and thiazolidinedione combination
Packing: 10 × 10 tablets in blister / Alu-Alu strips
Storage: Store below 30 °C, protected from light and moisture.

02Related

From the same category

View the category

Tablet
Sitagliptin + Metformin + Glimepiride
Sitagliptin + Metformin + GlimepirideTablet
Tablet
Teneligliptin + Metformin
Teneligliptin + MetforminTablet
Tablet
Vildagliptin + Metformin
Vildagliptin + MetforminTablet
Tablet
Dapagliflozin + Sitagliptin
Dapagliflozin + SitagliptinTablet
Tablet
Gliclazide + Metformin
Gliclazide + MetforminTablet
Tablet
Glimepiride + Voglibose
Glimepiride + VogliboseTablet